Şunu aradınız:: muskuloskeletali (Maltaca - İngilizce)

disturbi muskuloskeletali kronika
chronic musculoskeletal disorders:

komuni: uġigħ muskuloskeletali
common: musculoskeletal pain*

kwistjonijiet psikosoċjali u kondizzjonijiet muskuloskeletali,
psychosocial issues and musculoskeletal disorders,

disturbi muskuloskeletali u tat- tessuti konnettivi
musculoskeletal and connective tissue disorders

disturbi muskuloskeletali akuti: ittratta sa 6 ijiem.
acute musculoskeletal disorders treat: for up to 6 days.

uġigħ fl-għonq uġigħ muskuloskeletali fis-sider
neck pain musculoskeletal chest pain

inizjattiva tal-komunità dwar problemi muskuloskeletali relatati max-xogħol
community initiative on work-related musculoskeletal disorders

għal disturbi muskuloskeletali akuti, ikkura għal mhux aktar minn 6 ijiem.
for acute musculoskeletal disorders treat for up to 6 days.

mhux komuni: bugħawwiġ/ spażmi muskolari, uġigħ/ ebusija muskuloskeletali.
uncommon: proteinuria.

riskju ta’ disturbi muskuloskeletali, pereżempju mill-ġarr ta’ tagħbijiet jew meta jsir xogħol ripetittiv
challenges to safe and healthy cleaning

meloxivet tintuża fil-klieb sabiex titnaqqas l-infjammazzjoni u l-uġigħ fil-problemi muskuloskeletali.
meloxivet is used in dogs to relieve inflammation and pain in musculo-skeletal disorders.

11 sistema tal- ġisem passaġġ gastrointestinali newroloġika/ psikjatrija ematoloġika fwied/ frixa muskuloskeletali passaġġ respiratorju Ġilda uroloġija oħrajn
nausea, vomiting, diarrhoea, abdominal pain, mouth ulceration

il-problemi muskuloskeletali (msds) huma l-aktar problema komuni tassaħħa relatata max-xogħol fl-ewropa.
musculoskeletal disorders (msds) are the most common workrelated health problem in europe.

fi provi kliniċi fil- qtates, il- pilloli robenacoxib naqqsu l- uġigħ u l- infjammazzjoni assoċjata ma ’ disturbi muskuloskeletali.
in clinical trials in cats, robenacoxib tablets reduced pain and inflammation associated with musculoskeletal disorders.

mnaqqsa, ħalq niexef, vista baxxa, nawżja (tħossok mdardar) jew remettar, uġigħ addominali (taż - żaqq), dijarea, stomatitis (fjammazzjoni tad- dawra tal- ħalq), dyspepsia (indiġestjoni), alopeċja (telf ta ’ xagħar), jegħraq aktar, mijalġja (uġigħ fil- muskoli), artralġja (uġigħ fil- ġogi), uġigħ muskuloskeletali li l
the most common side effects with viraferon in adults (seen in more than 1 patient in 10) are leucopenia (low white blood cell counts), anorexia (loss of appetite), depression, insomnia (difficulty lon sleeping), anxiety, agitation, nervousness, dizziness, headache, impaired concentration, dry mouth, blurred vision, nausea (feeling sick) or vomiting, abdominal (tummy) pain, diarrhoea, stomatitis (inflammation of the lining of the mouth), dyspepsia (indigestion), alopecia (hair loss), increased sweating, myalgia (muscle pain), arthralgia (joint pain), musculoskeletal pain (pain in the muscles and bones), inflammation at the site of the injection, fatigue (tiredness), rigors (shaking chills), fever, flu- no